NASDAQ · HUM
Healthcare · Medical - Healthcare Plans
$385.54
Down-$7.09 (-1.81%)
Updated Aug 31, 2026, 12:38 PM
SID Score
7.5/10
Composite research score
Smart Money
62/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
HUM closed at $385.54 after 20 trading sessions, up 2.95% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $392.71 | $397.3271 | $385.22 | $385.54 | 746.6K |
| Aug 27, 2026 | $386.67 | $397.00 | $386.45 | $392.63 | 899.48K |
| Aug 26, 2026 | $390.00 | $403.15 | $386.55 | $391.06 | 908.16K |
| Aug 25, 2026 | $388.99 | $390.00 | $380.95 | $389.71 | 954.88K |
| Aug 24, 2026 | $380.49 | $389.85 | $379.27 | $386.61 | 1.46M |
| Aug 21, 2026 | $381.69 | $387.98 | $378.625 | $378.88 | 1.14M |
| Aug 20, 2026 | $374.29 | $387.79 | $374.29 | $380.73 | 1.32M |
| Aug 19, 2026 | $385.00 | $387.61 | $371.50 | $378.02 | 1.14M |
| Aug 18, 2026 | $384.00 | $392.525 | $381.69 | $382.00 | 741.19K |
| Aug 17, 2026 | $386.52 | $387.085 | $380.06 | $384.31 | 756.59K |
| Aug 14, 2026 | $384.00 | $389.70 | $380.085 | $389.05 | 761.09K |
| Aug 13, 2026 | $390.27 | $392.5767 | $382.51 | $384.97 | 754.15K |
| Aug 12, 2026 | $371.98 | $389.48 | $370.38 | $388.83 | 1.26M |
| Aug 11, 2026 | $386.51 | $389.53 | $371.96 | $372.82 | 733.25K |
| Aug 10, 2026 | $385.00 | $393.475 | $384.09 | $385.70 | 1.15M |
| Aug 7, 2026 | $364.00 | $385.66 | $363.775 | $385.00 | 1.41M |
| Aug 6, 2026 | $366.46 | $369.99 | $355.71 | $367.24 | 1.37M |
| Aug 5, 2026 | $362.80 | $367.92 | $353.69 | $363.82 | 1.49M |
| Aug 4, 2026 | $374.62 | $374.66 | $360.18 | $362.16 | 1.55M |
| Aug 3, 2026 | $365.00 | $374.52 | $360.76 | $374.50 | 1.39M |
The latest Smart Investors Daily articles mentioning HUM.
HUM research
Company profile and research snapshot.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | JP Morgan | Neutral | — |
| Aug 5, 2026 | Morgan Stanley | Equal-Weight | — |
| Jul 31, 2026 | TD Cowen | Hold | — |
| Jul 31, 2026 | Barclays | Equal-Weight | — |
| Jul 30, 2026 | Guggenheim | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 25, 2026
Launched July 1, this partnership builds on the organizations' long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the greatest impact.As
Yahoo · Aug 21, 2026
UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.
Yahoo · Aug 20, 2026
HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.
Yahoo · Aug 20, 2026
LOUISVILLE, Ky., August 20, 2026--Humana Inc. (NYSE: HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, healthcare executive, and technology leader, Dr. Nundy has spent his career using technology to make care better, simpler, and more human. At Humana, he will bring an innovative clinical voice to the enterprise and help shape the design of the company's products, platforms, and use of AI. Dr. Nundy will r
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HUM.
